Somatostatin-Producing Neuroendocrine Tumor

Somatostatin-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00655655	Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors	completed	Phase 1	96	Mayo ClinicOTHER	1	Aug 21, 2024	clinicaltrials
NCT01465659	Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery	completed	Phase 1 / Phase 2	29	Northwestern UniversityOTHER	1	Aug 5, 2021	clinicaltrials
NCT01204476	Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma	completed	Phase 1	27	National Cancer Institute (NCI)NIH	1	Jul 15, 2016	clinicaltrials
NCT00004074	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Data updated 23 days agoSource updated Aug 21, 2024source: clinicaltrials